Home › IntelliCyt And FIMM Announce A Collaboration To Advance Personalized Medicine In Cancer Treatment
 

Keywords :   


IntelliCyt And FIMM Announce A Collaboration To Advance Personalized Medicine In Cancer Treatment

2016-03-02 05:45:22| drugdiscoveryonline Home Page

IntelliCyt, a leading provider of integrated platforms that accelerate drug discovery, antibody screening and immuno-oncology research today announced a collaboration with the Institute for Molecular Medicine Finland (FIMM) at the University of Helsinki to further the development of personalized medicine in cancer treatment

Tags: treatment medicine advance cancer

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
17.05Johnson & Johnson Acquires Atopic Dermatitis Treatment Biotech Company
17.05Register For Sustainable Cosmetics Summit
17.05Fewer crackers in Ritz boxes but price remains same
17.05Eastern North Pacific Tropical Weather Outlook
17.05Boeing boss's $33m pay package approved
17.05Heifers and female cows remain hot topic at sale barn
17.05Dutch Boy Paints Introduces Professional Series at Menards
17.05Atlantic Tropical Weather Outlook
More »